Discover Medicines With the Power of AI: Profluent, Fueled by Salesforce Research and Endorsed by Jeff Dean
Last year, Salesforce, the company best known for its cloud sales support software (and Slack), spearheaded a project called ProGen to design proteins using generative AI.
“Many drugs — enzymes and antibodies, for example — consist of proteins,” Madani said.
Fed into a generative AI model, data about proteins can be used to predict entirely new proteins with novel functions.
Other companies and research groups have demonstrated viable ways in which generative AI can be used to predict proteins.
And DeepMind, Google’s AI research lab, has a system called AlphaFold that predicts complete protein structures, achieving speed and accuracy far surpassing older, less complex algorithmic methods.
